JPMorgan raises UCB SA stock outlook, doubles price target By Investing.com
JPMorgan raises UCB SA stock outlook, doubles price target…
189,975€
0,09%
Echtzeit-Aktienkurs UCB S.A.
Bid:
Ask:
Nachrichten zur UCB S.A. Aktie
ANALYSE-FLASH: JPMorgan hebt UCB auf 'Neutral' - Ziel deutlich hoch auf 150 Euro
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für die Aktien von UCB…
UCB SA (UCBJF) Full Year 2023 Earnings Call Transcript
…
Global Axial Spondyloarthritis (axSpA) Market Report 2023
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis (axSpA) Market Report 2023" report has been…
Active Pharmaceutical Ingredients (API) Market Size to Surpass USD 349.2 Billion Growth by 2030, Exhibit a CAGR of 6.5%
[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…
ClearPoint Neuro und UCB unterzeichnen Lizenzvereinbarung für die Verabreichung von Gentherapeutika
SOLANA BEACH, Kalifornien, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), ein weltweit tätiges Unternehmen,…
Veeva in pact with Belgian biopharma UCB for tech-driven clinical trials
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Govt starts inquiry into Google app payments antitrust compliance
The Competition Commission of India (CCI) has initiated an inquiry into Google after receiving allegations from Match Group and Indian…
XFRA : DIVIDEND/INTEREST INFORMATION - 28.04.2023 - BE0003739530
Das Instrument UNC BE0003739530 UCB S.A. EQUITY wird cum Dividende/Zinsen gehandelt am 27.04.2023 und ex Dividende/Zinsen am 28.04.2023
The instrument UNC…
UCB Convening Notice to the General Meeting of theShareholders 2023
The Board of Directors invites the shareholders for the general meeting of shareholders (the “General Meeting”) which will be held…
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been…